Project Grant HT94252510489
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The U.S. Defense Health Agency awarded a $505,270 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development (CFDA 12.420) program. The funding will support a 2-year research project (9/30/2025 - 9/29/2027) investigating the impact of the reprogrammed PIK3R1-insulin-glucose metabolism pathway in lethal prostate cancer, with the goal of developing new therapeutic strategies. ISMMS, a prominent academic medical center and federal...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
This $507,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the Icahn School of Medicine at Mount Sinai (ISMMS) to study the role of exosomes in promoting prostate cancer metastasis and resistance to androgen deprivation therapy. The 2-year grant, awarded on June 15, 2024, will enable ISMMS to conduct innovative biomedical research with the goal of advancing understanding and treatment of...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), has awarded a $2,028,000.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. The grant, awarded on April 1, 2025, will support the identification of epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. ISMMS, a prominent academic medical center and federal contractor, will leverage its...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,437 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to enhance the immunogenicity of nectin-4 targeted therapy for the treatment of aggressive bladder cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The federal Project Grant award of $202,800.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 30, 2025 to September 29, 2026, supports research by the Icahn School of Medicine at Mount Sinai to investigate "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis." The grant funds sophisticated scientific investigations and advanced medical...
The Icahn School of Medicine at Mount Sinai will receive $1,420,835 under a three-year Project Grant from the Defense Health Agency to target the immunosuppressive microenvironment of prostate cancer and enhance the therapeutic efficacy of immune checkpoint inhibitors. The grant, awarded June 1, 2023 under the Military Medical Research and Development program (CFDA 12.420), will support basic, applied, and advanced biomedical research aimed at transforming health care for service members and the...
This federal Project Grant award, valued at $1,312,000.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research efforts by the Regents of the University of California, San Francisco (UCSF) to upregulate and image Nectin4 in order to enhance Nectin4-targeted therapies for bladder cancer. The 4-year award, with a performance period from August 1, 2025 to July 31, 2029, will enable UCSF researchers to investigate...
The Icahn School of Medicine at Mount Sinai will receive $760,500 from the Defense Health Agency under a three-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to functionally identify high-dimensional driver combinations in basal-like breast cancer. Through February 1, 2023 to January 31, 2026, this award will support the Icahn School of Medicine's efforts to transform health care for service members and the...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...